Alterations of perineuronal nets in the dorsolateral prefrontal cortex of neuropsychiatric patients.

Bipolar disorder Major depression Parvalbumin Perineuronal nets Prefrontal cortex Schizophrenia

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
15 Nov 2019
Historique:
received: 17 07 2019
accepted: 08 10 2019
entrez: 16 11 2019
pubmed: 16 11 2019
medline: 16 11 2019
Statut: epublish

Résumé

Alterations in the structure and physiology of interneurons in the prefrontal cortex (PFC) are important factors in the etiopathology of different psychiatric disorders. Among the interneuronal subpopulations, parvalbumin (PV) expressing cells appear to be specially affected. Interestingly, during development and adulthood the connectivity of these interneurons is regulated by the presence of perineuronal nets (PNNs), specialized regions of the extracellular matrix, which are frequently surrounding PV expressing neurons. Previous reports have found anomalies in the density of PNNs in the PFC of schizophrenic patients. However, although some studies have described alterations in PNNs in some extracortical regions of bipolar disorder patients, there are no studies focusing on the prefrontocortical PNNs of bipolar or major depression patients. For this reason, we have analyzed the density of PNNs in post-mortem sections of the dorsolateral PFC (DLPFC) from the Stanley Neuropathology Consortium, which includes controls, schizophrenia, bipolar and major depression patients. We have not observed differences in the distribution of PV+ cells or PNNs, or in the percentage of PV+ interneurons surrounded by PNNs. The density of PV+ interneurons was similar in all the experimental groups, but there was a significantly lower density of PNNs in the DLPFC of bipolar disorder patients and a tendency towards a decrease in schizophrenic patients. No differences were found when evaluating the density of PV+ cells surrounded by PNNs. Interestingly, when assessing the influence of demographic data, we found an inverse correlation between the density of PNNs and the presence of psychosis. The present results point to prefrontocortical PNNs and their role in the regulation of neuronal plasticity as putative players in the etiopathology of bipolar disorder and schizophrenia. Our findings also suggest a link between these specialized regions of the extracellular matrix and the presence of psychosis.

Sections du résumé

BACKGROUND BACKGROUND
Alterations in the structure and physiology of interneurons in the prefrontal cortex (PFC) are important factors in the etiopathology of different psychiatric disorders. Among the interneuronal subpopulations, parvalbumin (PV) expressing cells appear to be specially affected. Interestingly, during development and adulthood the connectivity of these interneurons is regulated by the presence of perineuronal nets (PNNs), specialized regions of the extracellular matrix, which are frequently surrounding PV expressing neurons. Previous reports have found anomalies in the density of PNNs in the PFC of schizophrenic patients. However, although some studies have described alterations in PNNs in some extracortical regions of bipolar disorder patients, there are no studies focusing on the prefrontocortical PNNs of bipolar or major depression patients. For this reason, we have analyzed the density of PNNs in post-mortem sections of the dorsolateral PFC (DLPFC) from the Stanley Neuropathology Consortium, which includes controls, schizophrenia, bipolar and major depression patients.
RESULTS RESULTS
We have not observed differences in the distribution of PV+ cells or PNNs, or in the percentage of PV+ interneurons surrounded by PNNs. The density of PV+ interneurons was similar in all the experimental groups, but there was a significantly lower density of PNNs in the DLPFC of bipolar disorder patients and a tendency towards a decrease in schizophrenic patients. No differences were found when evaluating the density of PV+ cells surrounded by PNNs. Interestingly, when assessing the influence of demographic data, we found an inverse correlation between the density of PNNs and the presence of psychosis.
CONCLUSIONS CONCLUSIONS
The present results point to prefrontocortical PNNs and their role in the regulation of neuronal plasticity as putative players in the etiopathology of bipolar disorder and schizophrenia. Our findings also suggest a link between these specialized regions of the extracellular matrix and the presence of psychosis.

Identifiants

pubmed: 31728775
doi: 10.1186/s40345-019-0161-0
pii: 10.1186/s40345-019-0161-0
pmc: PMC6856240
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24

Subventions

Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : SAF2015-68436-R
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : IJCI-2016-27758

Références

Bipolar Disord. 2010 Feb;12(1):95-101
pubmed: 20148871
Science. 2014 Aug 1;345(6196):1255263
pubmed: 25082707
J Neurosci. 2016 Nov 9;36(45):11459-11468
pubmed: 27911749
Am J Psychiatry. 1997 Jul;154(7):1013-5
pubmed: 9210755
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5
pubmed: 23671099
Am J Psychiatry. 2012 Nov;169(11):1194-202
pubmed: 23128924
J Neurosci. 2003 Jul 16;23(15):6315-26
pubmed: 12867516
Annu Rev Neurosci. 2008;31:219-45
pubmed: 18558854
Nat Rev Neurosci. 2012 Jan 18;13(2):107-20
pubmed: 22251963
J Neurosci. 2015 Feb 18;35(7):3201-6
pubmed: 25698754
Mol Psychiatry. 2008 Feb;13(2):147-61
pubmed: 17471287
Schizophr Res. 1997 Apr 11;24(3):349-55
pubmed: 9134596
Mol Cell Neurosci. 2001 Jan;17(1):226-40
pubmed: 11161481
Front Cell Neurosci. 2018 May 30;12:149
pubmed: 29899690
J Affect Disord. 2008 Dec;111(2-3):135-44
pubmed: 18539338
Dev Neurobiol. 2011 Nov;71(11):1073-89
pubmed: 21898855
Int J Neuropsychopharmacol. 2011 Jul;14(6):721-34
pubmed: 21226980
Arch Gen Psychiatry. 2010 Feb;67(2):155-66
pubmed: 20124115
eNeuro. 2016 Jul 27;3(4):
pubmed: 27570824
Elife. 2015 Mar 03;4:null
pubmed: 25735038
eNeuro. 2017 May 1;4(2):
pubmed: 28466069
Neurosci Lett. 2012 Nov 14;530(1):97-102
pubmed: 23022470
Biol Psychiatry. 2003 Sep 1;54(5):515-28
pubmed: 12946880
Arch Gen Psychiatry. 1995 Apr;52(4):258-66
pubmed: 7702443
Front Cell Neurosci. 2019 May 07;13:197
pubmed: 31133813
Mol Psychiatry. 2018 Oct;23(10):2057-2065
pubmed: 29180672
Biol Psychiatry. 2002 Oct 1;52(7):708-15
pubmed: 12372661
Science. 2002 Nov 8;298(5596):1248-51
pubmed: 12424383
Arch Gen Psychiatry. 2007 Feb;64(2):193-200
pubmed: 17283286
Cell Tissue Res. 2012 Jul;349(1):147-60
pubmed: 22437874
Neuroscience. 2017 May 14;350:13-22
pubmed: 28323012
Neuroscience. 1996 Dec;75(4):1021-31
pubmed: 8938738
Biol Psychiatry. 2013 Sep 15;74(6):427-35
pubmed: 23790226
Dev Neurobiol. 2007 Apr;67(5):570-88
pubmed: 17443809
Sci Rep. 2015 Dec 01;5:16471
pubmed: 26621052
Eur J Neurosci. 2000 Sep;12(9):3331-42
pubmed: 10998116
Arch Gen Psychiatry. 2000 Nov;57(11):1061-9
pubmed: 11074872
Mol Cell Neurosci. 2003 Oct;24(2):271-82
pubmed: 14572452
Neurochem Int. 2012 Dec;61(7):963-72
pubmed: 22954428
Am J Psychiatry. 2001 Feb;158(2):256-65
pubmed: 11156808
Am J Geriatr Psychiatry. 2011 Feb;19(2):132-41
pubmed: 20808096
Curr Opin Psychiatry. 2016 May;29(3):202-10
pubmed: 26900672
Neurochem Res. 2013 Jun;38(6):1122-33
pubmed: 23354722
Neuropsychopharmacology. 2007 Feb;32(2):471-82
pubmed: 17063153
J Psychiatr Res. 2018 Jul;102:261-274
pubmed: 29753198
Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35
pubmed: 21126177
Neuron. 2017 Aug 2;95(3):639-655.e10
pubmed: 28712654
Neuroscience. 2019 Jan 1;396:24-35
pubmed: 30448452
Schizophr Res. 2000 Aug 3;44(2):151-5
pubmed: 10913747
Sci Rep. 2016 Nov 23;6:37580
pubmed: 27876866
Neuropsychopharmacology. 2016 Aug;41(9):2206-14
pubmed: 26868058
Trends Neurosci. 2012 Jan;35(1):57-67
pubmed: 22154068
Nature. 2009 Jun 4;459(7247):698-702
pubmed: 19396159
Neuropharmacology. 2012 Mar;62(3):1584-97
pubmed: 21856318
Schizophr Bull. 2015 Jan;41(1):180-91
pubmed: 24361861
Behav Brain Res. 2017 May 30;326:44-51
pubmed: 28238824
J Psychiatr Res. 2019 Jul;114:178-207
pubmed: 31096178

Auteurs

Julia Alcaide (J)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain.

Ramón Guirado (R)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain.

Carlos Crespo (C)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain.

José Miguel Blasco-Ibáñez (JM)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain.

Emilio Varea (E)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain.

Julio Sanjuan (J)

Department of Medicine, Universitat de València, Valencia, Spain.
CIBERSAM: Spanish National Network for Research in Mental Health, Madrid, Spain.
Fundación Investigación Hospital Clínico de Valencia, INCLIVA, Valencia, Spain.

Juan Nacher (J)

Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de Valencia, Dr. Moliner 50, 46100, Burjassot, Spain. nacher@uv.es.
CIBERSAM: Spanish National Network for Research in Mental Health, Madrid, Spain. nacher@uv.es.
Fundación Investigación Hospital Clínico de Valencia, INCLIVA, Valencia, Spain. nacher@uv.es.

Classifications MeSH